141 related articles for article (PubMed ID: 33680048)
1. Epidrug Modulated Expression of MiR--152 and MiR-148a Reverse Cisplatin Resistance in Ovarian Cancer Cells: An Experimental In-vitro Study.
Khajehnoori S; Zarei F; Mazaheri M; Dehghani-Firoozabadi A
Iran J Pharm Res; 2020; 19(3):509-519. PubMed ID: 33680048
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in gastric cancer.
Zhu A; Xia J; Zuo J; Jin S; Zhou H; Yao L; Huang H; Han Z
Med Oncol; 2012 Dec; 29(4):2701-9. PubMed ID: 22167392
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-148a-3p inhibits the proliferation of cervical cancer cells by regulating the expression levels of DNMT1 and UTF1.
Chen Q; Wang Y; Dang H; Wu X
Oncol Lett; 2021 Aug; 22(2):617. PubMed ID: 34257725
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-148a is silenced by hypermethylation and interacts with DNA methyltransferase 1 in hepatocellular carcinogenesis.
Long XR; He Y; Huang C; Li J
Int J Oncol; 2014 Jun; 44(6):1915-22. PubMed ID: 24714841
[TBL] [Abstract][Full Text] [Related]
5. Integrated Nanovaccine with MicroRNA-148a Inhibition Reprograms Tumor-Associated Dendritic Cells by Modulating miR-148a/DNMT1/SOCS1 Axis.
Liu L; Yi H; Wang C; He H; Li P; Pan H; Sheng N; Ji M; Cai L; Ma Y
J Immunol; 2016 Aug; 197(4):1231-41. PubMed ID: 27421476
[TBL] [Abstract][Full Text] [Related]
6. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.
Xiang Y; Ma N; Wang D; Zhang Y; Zhou J; Wu G; Zhao R; Huang H; Wang X; Qiao Y; Li F; Han D; Wang L; Zhang G; Gao X
Oncogene; 2014 Jan; 33(3):378-86. PubMed ID: 23318422
[TBL] [Abstract][Full Text] [Related]
7. RUNX3 inhibits laryngeal squamous cell carcinoma malignancy under the regulation of miR-148a-3p/DNMT1 axis.
Jili S; Eryong L; Lijuan L; Chao Z
Cell Biochem Funct; 2016 Dec; 34(8):597-605. PubMed ID: 27859417
[TBL] [Abstract][Full Text] [Related]
8. miR-148a dependent apoptosis of bladder cancer cells is mediated in part by the epigenetic modifier DNMT1.
Lombard AP; Mooso BA; Libertini SJ; Lim RM; Nakagawa RM; Vidallo KD; Costanzo NC; Ghosh PM; Mudryj M
Mol Carcinog; 2016 May; 55(5):757-67. PubMed ID: 25865490
[TBL] [Abstract][Full Text] [Related]
9. Antagonistic activities of miR-148a and DNMT1: Ectopic expression of miR-148a impairs DNMT1 mRNA and dwindle cell proliferation and survival.
Sengupta D; Deb M; Patra SK
Gene; 2018 Jun; 660():68-79. PubMed ID: 29596883
[TBL] [Abstract][Full Text] [Related]
10. miR-148a suppresses cell invasion and migration in gastric cancer by targeting DNA methyltransferase 1.
Shi H; Chen X; Jiang H; Wang X; Yu H; Sun P; Sui X
Oncol Lett; 2018 Apr; 15(4):4944-4950. PubMed ID: 29541249
[TBL] [Abstract][Full Text] [Related]
11. Reciprocal Regulation Between miR-148a/152 and DNA Methyltransferase 1 Is Associated with Hyperhomocysteinemia-Accelerated Atherosclerosis.
Yang A; Sun Y; Gao Y; Yang S; Mao C; Ding N; Deng M; Wang Y; Yang X; Jia Y; Zhang H; Jiang Y
DNA Cell Biol; 2017 Jun; 36(6):462-474. PubMed ID: 28472596
[TBL] [Abstract][Full Text] [Related]
12. miR-148a-3p Suppresses the Proliferation and Invasion of Esophageal Cancer by Targeting DNMT1.
Wang Y; Hu Y; Guo J; Wang L
Genet Test Mol Biomarkers; 2019 Feb; 23(2):98-104. PubMed ID: 30735457
[TBL] [Abstract][Full Text] [Related]
13. miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer.
Wang X; Liang Z; Xu X; Li J; Zhu Y; Meng S; Li S; Wang S; Xie B; Ji A; Liu B; Zheng X; Xie L
Cell Death Dis; 2016 Dec; 7(12):e2503. PubMed ID: 27906180
[TBL] [Abstract][Full Text] [Related]
14. miR-148a plays a pivotal role in the liver by promoting the hepatospecific phenotype and suppressing the invasiveness of transformed cells.
Gailhouste L; Gomez-Santos L; Hagiwara K; Hatada I; Kitagawa N; Kawaharada K; Thirion M; Kosaka N; Takahashi RU; Shibata T; Miyajima A; Ochiya T
Hepatology; 2013 Sep; 58(3):1153-65. PubMed ID: 23532995
[TBL] [Abstract][Full Text] [Related]
15. MiR-148a promotes myocardial differentiation of human bone mesenchymal stromal cells via DNA methyltransferase 1 (DNMT1).
Jiang C; Gong F
Cell Biol Int; 2018 Aug; 42(8):913-922. PubMed ID: 28656724
[TBL] [Abstract][Full Text] [Related]
16. The Interplay Between miR-148a and DNMT1 Might be Exploited for Pancreatic Cancer Therapy.
Zhan Q; Fang Y; Deng X; Chen H; Jin J; Lu X; Peng C; Li H; Shen B
Cancer Invest; 2015; 33(7):267-75. PubMed ID: 25950085
[TBL] [Abstract][Full Text] [Related]
17. [Regulation and mechanism of miR-148a on cardiomyocyte differentiation induced by 5-aza in mesenchymal stem cells].
Jiang CK; Gong F
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2017 Jun; 33(6):514-518. PubMed ID: 29931900
[TBL] [Abstract][Full Text] [Related]
18. [Effects of 5-Aza-2'-deoxycytidine and trichostatin A on DNA methylation and expression of hMLH1 in ovarian cancer cell line COC1/DDP].
Meng CF; Dai DQ; Guo KJ
Ai Zheng; 2008 Dec; 27(12):1251-5. PubMed ID: 19079988
[TBL] [Abstract][Full Text] [Related]
19. Modulation of FABP4 hypomethylation by DNMT1 and its inverse interaction with miR-148a/152 in the placenta of preeclamptic rats and HTR-8 cells.
Yang A; Zhang H; Sun Y; Wang Y; Yang X; Yang X; Zhang H; Guo W; Zhu G; Tian J; Jia Y; Jiang Y
Placenta; 2016 Oct; 46():49-62. PubMed ID: 27697222
[TBL] [Abstract][Full Text] [Related]
20. MiR-148a suppressed cell invasion and migration via targeting WNT10b and modulating β-catenin signaling in cisplatin-resistant colorectal cancer cells.
Shi L; Xi J; Xu X; Peng B; Zhang B
Biomed Pharmacother; 2019 Jan; 109():902-909. PubMed ID: 30551544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
